Join our next Continuing Medical Education project “Carcinoma Uroteliale Metastatico 2.0”

Diatech Pharmacogenetics is pleased to announce its new Continuing Medical Education project “Carcinoma Uroteliale Metastatico 2.0. Nuove prospettive terapeutiche della medicina di precisione”, co-sponsored with Johnson&Johnson

Don’ t miss it on December 15 at 3.00 PM. 

Days
Hours
Minutes
logo Diatech Pharmacogenetics

Subscribe to Our Newsletter